baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Goldman Sachs Knock-Out ACS/ DE000GG0Y8K2 /

9/25/2024 9:59:47 AM	Chg.-0.030	Bid10:00:24 PM	Ask10:00:24 PM	Underlying	Strike price	Expiration date	Option type
0.090EUR	-25.00%	- Bid Size: -	- Ask Size: -	ACS ACTIVIDADES CONS...	43.0503 EUR	12/31/2078	Put

Newsfile Corp 9/6 Air & Energy of NWFL Introduces Comprehensive Energy Efficiency Audits, Enhancing Pensacola Air Cond...

GlobeNewswire 8/29 ACGME Names Mary E. Klingensmith, MD Next Chief Accreditation Officer

GlobeNewswire 8/27 Parsons Selected as Lead Engineer to Add Express Toll Lanes to State Route 400 in Georgia

GlobeNewswire 8/26 Stop & Shop Announces Plans to Stop Selling Tobacco Products

GlobeNewswire 8/22 Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Me...

GlobeNewswire 8/22 Skye Bioscience Launches Phase 2 CBeyond Clinical Trial of its Differentiated CB1 Inhibitor, Nimacim...

GlobeNewswire 8/21 ProLynx announces preclinical results of long-acting semaglutide requiring once monthly dosing

GlobeNewswire 8/21 Rose Hill Announces Addition of Two Senior Advisors to Advisory Team

GlobeNewswire 8/19 Auron Presents Preclinical Data at American Chemical Society Annual Meeting

Newsfile Corp 8/15 Droplet Lab Launches Innovative Instrument Set to Elevate Chemistry and Material Science Education

GlobeNewswire 8/15 NobleAI to Present at American Chemical Society’s Fall Conference, “Elevating Chemistry”

GlobeNewswire 8/6 Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug

GlobeNewswire 8/6 SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article...

GlobeNewswire 8/2 FDA has accepted a BLA for bentracimab, the first and only ticagrelor reversal agent, for filing and...

GlobeNewswire 7/30 Award-Winning Material Inventor Joins as Advisor for AI Innovator of Climate Technologies

GlobeNewswire 7/30 NewHydrogen CEO Steve Hill Explores AI’s Role in Cutting-Edge Hydrogen Solutions with Renowned Compu...

TeleTrader 7/17 Samsung to launch AI-powered ACs in N. America

GlobeNewswire 7/3 NH TherAguix Announces Publication of Groundbreaking Study on AGuIX® Nanoparticles Enhancing Cervica...

GlobeNewswire 7/3 Advantest to Showcase Latest Test Technology at SEMICON West 2024, July 9-11, in San Francisco

GlobeNewswire 7/2 Ipsen expands collaboration and license agreement for development of Cabometyx® in advanced neuroend...

GlobeNewswire 6/25 Sustainable Mom and Baby Brands Commit to Tackling Global Plastic Pollution with rePurpose Global

GlobeNewswire 6/21 Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in...

GlobeNewswire 6/17 ACS Journal Validates HydroGraph Cement Performance

GlobeNewswire 6/12 Intelligent Product Solutions Launches Advanced Concept Studio (ACS) Division Focused on Industrial ...

GlobeNewswire 6/10 Noodles & Company Appoints Britain Peakes to its Board of Directors

Goldman Sachs Knock-Out ACS/ DE000GG0Y8K2 /

If you wish to receive reply to your feedback, please provide your email address.